This topic contains a solution. Click here to go to the answer

Author Question: A 49-year-old patient with multiple sclerosis (MS) is to begin treatment with glatiramer acetate ... (Read 127 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
A 49-year-old patient with multiple sclerosis (MS) is to begin treatment with glatiramer acetate (Copaxone). Which information will the nurse include in patient teaching?
 
  a. Recommendation to drink at least 4 L of fluid daily
  b. Need to avoid driving or operating heavy machinery
  c. How to draw up and administer injections of the medication
  d. Use of contraceptive methods other than oral contraceptives

Question 2

Which information about a 60-year-old patient with MS indicates that the nurse should consult with the health care provider before giving the prescribed dose of dalfampridine (Ampyra)?
 
  a. The patient has relapsing-remitting MS.
  b. The patient walks a mile a day for exercise.
  c. The patient complains of pain with neck flexion.
  d. The patient has an increased serum creatinine level.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

samiel-sayed

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

ANS: C
Copaxone is administered by self-injection. Oral contraceptives are an appropriate choice for birth control. There is no need to avoid driving or drink large fluid volumes when taking glatiramer.

Answer to Question 2

ANS: D
Dalfampridine should not be given to patients with impaired renal function. The other information will not impact whether the dalfampridine should be administered.




Sufayan.ah

  • Member
  • Posts: 512
Reply 2 on: Jun 25, 2018
:D TYSM


adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Excellent

 

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

For a complete list of videos, visit our video library